Zyversa Therapeutics Inc
(ZVSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 2,754 | 2,827 | 13,935 | 2,903 | 86,325 |
| Operating Income | -2,754 | -2,827 | -13,935 | -2,903 | -86,325 |
| Pre-tax Income | -2,754 | -2,827 | -13,935 | -2,903 | -86,325 |
| Income Tax | 10 | N/A | -597 | 1 | -7,812 |
| Net Income Continuous | -2,764 | -2,827 | -13,338 | -2,903 | -78,513 |
| Net Income | $-2,764 | $-2,827 | $-13,339 | $-2,902 | $-78,513 |
| EPS Basic Total Ops | -3.31 | -4.53 | 770.48 | -30.18 | -1,694.12 |
| EPS Basic Continuous Ops | -3.31 | -4.53 | 697.53 | -29.93 | -1,539.47 |
| EPS Diluted Total Ops | -3.31 | -4.53 | 770.48 | -30.18 | -1,694.12 |
| EPS Diluted Continuous Ops | -3.31 | -4.53 | 697.53 | -29.93 | -1,539.47 |
| EPS Diluted Before Non-Recurring Items | -3.31 | -4.53 | N/A | N/A | N/A |
| EBITDA(a) | $-2,751 | $-2,824 | $-13,932 | $-2,900 | $-74,427 |